KURIYEL RALF (Senior VP, R&D) sold 12.7% of their position (3.52K shares) of REPLIGEN CORP on the open market
Open‑market sale worth $681.3K — a moderate reduction. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 1 sale
Filed: 3/12/2024ACC: 0000950170-24-030331
-975.00
Net shares
Net seller
$681.3K
Total sold
1
Open market trades
0B · 1S
3
Total transactions
2.54K acquired · 3.52K disposed
Non-Derivative Transactions2
Common Stock
Direct
Shares
+1.27K
Price / share
$86.10
Trade value
$109.43K
% of position
4.8%
3/11/2024
26.51K→27.78K
Common Stock
Direct
Shares
−3.52K
Price / share
$193.73
Trade value
$681.35K
% of position
12.7%
3/11/2024
27.78K→24.26K
Total
Net shares
−2.25K
Net value
-$571.92K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 3/11/2024 | M · Option Exercise | +1.27K | $86.10 | $109.43K | 4.8% | 26.51K | 27.78K |
| Common Stock Direct | 3/11/2024 | S · Sale | −3.52K | $193.73 | $681.35K | 12.7% | 27.78K | 24.26K |
| Total | −2.25K | -$571.92K | ||||||
Derivative Transactions1
Stock Option (Right to Buy)
Direct
Converts to
Common Stock
1.27K shares
Shares
+1.27K
Strike price
86.10
Held after
0.00
Exercisable
—
3/11/2024
| Security | Converts To | Date | Type | Shares | Strike Price | Exercisable | Held After |
|---|---|---|---|---|---|---|---|
| Stock Option (Right to Buy) Direct | Common Stock1.27K shares | 3/11/2024 | M · Option Exercise | +1.27K | 86.10 | — | 0.00 |